Clinical Trial Update: CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1 [Phase 3]

View source ↗

Summary

CREATE-1 is a Phase 3 study evaluating the efficacy and safety of AXS-02 in patients with Complex Regional Pain Syndrome (CRPS-1). The status of the trial is un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complex Regional Pain Syndrome

Drugs mentioned

• AXS-02

Snippet

Sponsor: Axsome Therapeutics, Inc. | Conditions: Complex Regional Pain Syndrome, Reflex Sympathetic Dystrophy | Phase 3 | Status: UNKNOWN